Showing results (391-400 of 658) with videos related to
Sort By:
Pageof 66
Ear, Nose, & Throat Journal|December 23, 2021
Physical Therapy for Muscle Tension Dysphonia with CervicalgiaAlan D Tate, Carey A Tomlinson, David Oliver Francis, et al.Biorxiv : the Preprint Server for Biology|June 21, 2024
Targeting the sphingolipid rheostat in IDH1 glioma alters cholesterol homeostasis and triggers apoptosis via membrane degradationTyrone Dowdy, Helena Muley Vilamu, Adrian Lita, et al.Neurosurgery|February 26, 2019
Perilesional Resection of Glioblastoma Is Independently Associated With Improved OutcomesWajd N Al-Holou, Tiffany R Hodges, Richard G Everson, et al.Journal of Neurosurgery|May 1, 2026
Individualized multiparadigm mapping and standardized tablet-based task administration during awake craniotomy: associations with return to work and survival in diffuse gliomasEsteban Ramirez Ferrer, Kyle Noll, David S Sabsevitz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2026
Systemic immune correlates of long-term survival after Delta-24-RGD based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)Chibawanye I Ene, Sanjay Singh, Thiagarajan Venkataraman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant GliomasAlessandro Canella, Alessandra M Welker, Ji Young Yoo, et al.Neuro-Oncology Advances|March 13, 2026
Perioperative neurocognitive functioning in elderly patients undergoing awake craniotomy for high grade gliomaEric A Goethe, Kyle R Noll, Subhiksha Srinivasan, et al.Cancer Research|May 3, 2013
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of gliomaJun Wei, Fei Wang, Ling-Yuan Kong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2003
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical resultsFrederick F Lang, Janet M Bruner, Gregory N Fuller, et al.Pageof 66